Easyreo Of Central Florida LLC is categorized under Internal Medicine Doctors in Melbourne, FL and active since 2009.
Easyreo Of Central Florida LLC was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Rico Colon at the company’s single location by writing to 221 West Hibiscus Boulevard, Melbourne, Florida FL 32901 or by phoning (321) 768-9575. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Easyreo Of Central Florida LLC |
Contact Person: | Rico Colon |
Address: | 221 West Hibiscus Boulevard, Melbourne, Florida 32901 |
Phone Number: | (321) 768-9575 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2009 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Easyreo Of Central Florida LLC was started in 2009 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Rico Colon for inquiries that concern Easyreo Of Central Florida LLC by calling the company number (321) 768-9575, as your correspondence is most welcome. Additionally, the physical location of the single location of Easyreo Of Central Florida LLC can be found at the coordinates 28.085096,-80.626376 as well as the street address 221 West Hibiscus Boulevard in Melbourne, Florida 32901.
For its online presence, you may visit Easyreo Of Central Florida LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.